Bridgeway Capital Management’s Ocean Bio-Chem Inc OBCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,798
Closed -$165K 1479
2022
Q2
$165K Hold
12,798
﹤0.01% 1131
2022
Q1
$103K Hold
12,798
﹤0.01% 1256
2021
Q4
$111K Hold
12,798
﹤0.01% 1209
2021
Q3
$119K Hold
12,798
﹤0.01% 1241
2021
Q2
$156K Hold
12,798
﹤0.01% 1283
2021
Q1
$154K Hold
12,798
﹤0.01% 1303
2020
Q4
$171K Sell
12,798
-11,777
-48% -$169K ﹤0.01% 1228
2020
Q3
$352K Buy
24,575
+10,900
+80% +$165K 0.01% 1006
2020
Q2
$191K Buy
+13,675
New +$91.2K ﹤0.01% 1160

Bridgeway Capital Management's OBCI Position: Q3 2022 in Review

Bridgeway Capital Management sold out of Ocean Bio-Chem Inc (OBCI) in Q3 2022, closing a stake of 12,798 shares — an estimated $165K sold.

Bridgeway Capital Management first reported a position in OBCI in Q2 2020 and held it in 9 quarters. The position peaked at $352K in Q3 2020. 0 funds tracked by Wall St. Rank hold OBCI as of Q3 2022.

  • Bridgeway Capital Management reported no remaining Ocean Bio-Chem Inc position as of Q3 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 12,798 Ocean Bio-Chem Inc shares in Q3 2022, an estimated $165K.
  • Bridgeway Capital Management first reported a position in Ocean Bio-Chem Inc in Q2 2020 and held it in 9 quarters.
  • Bridgeway Capital Management's Ocean Bio-Chem Inc position peaked at $352K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Ocean Bio-Chem Inc as of Q3 2022.

Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.